Soy Protein Favorably Affects LDL Size Independently of Isoflavones in Hypercholesterolemic Men and Women

Journal of Nutrition

Volumn 134, Issue 3, 2004, Pages 574-579

  Desroches, Sophie ^a   Mauger, Jean François ^a   Ausman, Lynne M ^b   Lichtenstein, Alice H ^b   Lamarche, Benoît ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Isoflavones; LDL size; Lipids; Lipoproteins; Soy protein

Indexed keywords

ISOFLAVONE; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN;

ADULT; AGED; ANIMAL PRODUCT; ARTICLE; ATHEROGENESIS; CHOLECYSTOKININ BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DIET; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SOYBEAN;

ANIMALIA; GLYCINE MAX;

EID: 1542286864     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.3.574     Document Type: Article

References (34)

1. Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W., Kris-Etherton, P., Goldberg, I. J., et al. (2000) AHA Dietary Guidelines. Revision 2000: a statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation 102: 2284-2299.
2. Yu-Poth, S., Zhao, G., Etherton, T., Naglak, M., Jonnalagadda, S. & Kris-Etherton, P. M. (1999) Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am. J. Clin. Nutr. 69: 632-646.
3. Baum, J. A., Teng, H., Erdman, J. W., Weigel, R. M., Klein, B. P., Persky, V. W., Freels, S., Surya, P., Bakhit, R. M. et al. (1998) Long term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am. J. Clin. Nutr. 68: 545-551.
4. Crouse, J. R., III, Morgan, T., Terry, J. G., Ellis, J., Vitolins, M. & Burke, G.L. (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Intern. Med. 159: 2070-2076.
5. Teixeira, S. R., Potter, S. M., Weigel, R., Hannum, S., Erdman, J. W. & Hasler, C. M. (2000) Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am. J. Clin. Nutr. 71: 1077-1084.
6. Anthony, M. S., Clarkson, T. B., Bullock, B. C. & Wagner, J. D. (1997) Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler. Thromb. Vasc. Biol. 17: 2524-2531.
7. Kritchevsky, D. (1995) Dietary protein, cholesterol and atherosclerosis: a review of the early history. J. Nutr. 125: 589S-593S.
8. Anderson, J. W., Johnstone, B. M. & Cook-Newell, M. E. (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333: 276-282.
9. Gardner, C. D., Newell, K. A., Cherin, R. & Haskell, W. L. (2001) The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am. J. Clin. Nutr. 73: 728-735.
10. Merz-Demlow, B. E., Duncan, A. M., Wangen, K. E., Xu, X., Carr, T. P., Phipps, W. R. & Kurzer, M. S. (2000) Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am. J. Clin. Nutr. 71: 1462-1469.
11. Wangen, K. E., Duncan, A. M., Xu, X. & Kurser, M. S. (2001) Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am. J. Clin. Nutr. 73: 225-231.
12. Nestel, P. J., Yamashita, T., Sasahara, T., Pomeroy, S., Dart, A., Komesaroff, P., Owen, A. & Abbey, M. (1997) Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler. Thromb. Vasc. Biol. 17: 3392-3398.
13. Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J. & Despres, J. P. (1997) Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec cardiovascular study. Circulation 95: 69-75.
14. Gardner, C. D., Fortmann, S. P. & Krauss, R. M. (1996) Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. J. Am. Med. Assoc. 276: 875-881.
15. St-Pierre, A. C., Ruel, I. L., Cantin, B., Dagenais, G. R., Bernard, P. M., Després, J. P. & Lamarche, B. (2001) Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104: 2295-2299.
16. Dreon, D. M., Fernstrom, H. A., Campos, H., Blanche, P., Williams, P. T. & Krauss,R.M. (1998) Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am. J. Clin. Nutr. 67: 828-836.
17. Dreon, D. M., Fernsrom, H. A., Williams, P. T. & Krauss, R. M. (1997) LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women. Arterioscler. Thromb. Vasc. Biol. 17: 707-714.
18. Lichtenstein, A. H., Jalbert, S. M., Adlercreutz, H., Goldin, B. R., Rasmussen, H., Schaefer, E. J. & Ausman, L. M. (2002) Lipoprotein response to diets high in soy or animal protein without and with Isoflavones in moderately hypercholesterolemic subjects. Arterioscler. Thromb. Vasc. Biol. 22: 1852-1858.
19. McNamara, J. R. & Schaefer, E. J. (1987) Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin. Chim. Acta 166: 1-8.
20. -+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
21. Tchernof, A., Lamarche, B., Prud'homme, D., Nadeau, A., Moorjani, S., Labrie, F., Lupien, P. J. & Després, J. P. (1996) The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19: 629-637.
22. Department of Health and Human Services, Food and Drug Administration. Food labeling: health claims; soy protein and coronary heart disease. http://vm.cfsan.fda.gov/lrd/fr991026.html [accessed 10/29/2003].
23. Erdman, J. W. (2000) Soy protein and cardiovascular disease: a statement for healthcare professionals from the nutrition committee of the AHA. Circulation 102: 2555-2559.
24. Jenkins, D.J.A., Kendall, C.W.C., Jackson, C.J.C., Connelly, P. W., Parker, T., Faulkner, D., Vidgen, E., Cunnane, S. C., Leiter, L. A. & Josse, R. G. (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am. J. Clin. Nutr. 76: 365-372.
25. Wiseman, H., O'Reilly, J.D.O., Adlercreutz, H., Mallet, A. I., Bowey, E. A., Rowland, I. R. & Sanders, T.A.B. (2000) Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 72: 395-400.
26. Anthony, M. S., Clarkson, T. B. & Williams, J. K. (1998) Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am. J. Clin. Nutr. 68 (suppl.): 139OS-1393S.
27. Krauss, R. M. & Dreon, D. M. (1995) Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am. J. Clin. Nutr. 62: 478S-487S.
28. Lamarche, B., Lemieux, I. & Després, J. P. (1999) The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab. 25: 199-211.
29. Vessby, B., Karlstrom, B., Lithell, H., Gustafsson, I. B. & Werner, I. (1982) The effects on lipid and carbohydrate metabolism of replacing some animal protein by soy-protein in a lipid-lowering diet for hypercholesterolemic patients. Hum. Nutr. Appl. Nutr. 36: 179-189.
30. Higashi, K., Abata, S., Iwamoto, N., Ogura, M., Yamashita, T., Ishikawa, O., Ohslzu, F. & Nakamura, H. (2001) Effects of soy protein on levels of remnant-like particles cholesterol and vitamin E in healthy men. J. Nutr. Sci. Vitaminol. 47: 283-288.
31. Demonty, I., Deshales, Y., Lamarche, B. & Jacques, H. (2002) Interaction between dietary protein and fat in triglyceride metabolism in the rat: effects of soy protein and menhaden oil. Lipids 37: 693-699.
32. McNamara, J. R., Small, D. M., Li, Z. & Schaefer, E. J. (1996) Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B. J. Lipid Res. 37: 1924-1935.
33. Packard, C. J., Demant, T., Stewart, J. P., Bedford, D., Caslake, M. J., Schwertfeger, G., Bedynek, A., Shepherd, J. & Seidel, D. (2000) Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J. Lipid Res. 41: 305-318.
34. Lamarche, B., St-Pierre, A., Ruel, I., Cantin, B., Dagenais, G. R. & Després, J. P. (2001) A prospective population based study of LDL particle size as a risk factor for ischemic heart disease in men. Can. J. Cardiol. 17: 859-865.